HealthEquity, Inc. $HQY Shares Acquired by Nordea Investment Management AB

Nordea Investment Management AB grew its position in HealthEquity, Inc. (NASDAQ:HQY) by 0.3% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 59,732 shares of the company’s stock after purchasing an additional 164 shares during the period. Nordea Investment Management AB owned approximately 0.07% of HealthEquity worth $6,319,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of the company. WCM Investment Management LLC lifted its stake in shares of HealthEquity by 7.0% in the 2nd quarter. WCM Investment Management LLC now owns 248,950 shares of the company’s stock valued at $26,110,000 after purchasing an additional 16,309 shares in the last quarter. Mutual Advisors LLC lifted its stake in shares of HealthEquity by 13.7% in the 2nd quarter. Mutual Advisors LLC now owns 5,880 shares of the company’s stock valued at $565,000 after purchasing an additional 708 shares in the last quarter. Sequoia Financial Advisors LLC lifted its stake in shares of HealthEquity by 78.6% in the 2nd quarter. Sequoia Financial Advisors LLC now owns 29,731 shares of the company’s stock valued at $3,115,000 after purchasing an additional 13,086 shares in the last quarter. Index Fund Advisors Inc. acquired a new position in shares of HealthEquity in the 2nd quarter valued at about $246,000. Finally, Vanguard Personalized Indexing Management LLC lifted its stake in shares of HealthEquity by 27.0% in the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 10,639 shares of the company’s stock valued at $1,115,000 after purchasing an additional 2,263 shares in the last quarter. 99.55% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities analysts recently commented on the company. Raymond James Financial reissued a “strong-buy” rating and set a $120.00 price target (up from $115.00) on shares of HealthEquity in a research report on Tuesday, July 8th. Royal Bank Of Canada boosted their price target on HealthEquity from $109.00 to $110.00 and gave the stock an “outperform” rating in a research report on Wednesday, September 3rd. KeyCorp reduced their price target on HealthEquity from $125.00 to $120.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 8th. Barrington Research reissued an “outperform” rating and set a $125.00 price target on shares of HealthEquity in a research report on Friday, August 29th. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of HealthEquity in a research report on Wednesday, October 8th. One investment analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $121.31.

HealthEquity Price Performance

HQY stock opened at $93.03 on Tuesday. The company has a quick ratio of 4.23, a current ratio of 4.23 and a debt-to-equity ratio of 0.47. HealthEquity, Inc. has a 52-week low of $74.07 and a 52-week high of $116.65. The stock’s 50 day moving average is $91.71 and its two-hundred day moving average is $94.20. The company has a market capitalization of $8.02 billion, a PE ratio of 56.38, a P/E/G ratio of 1.32 and a beta of 0.47.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings data on Tuesday, September 2nd. The company reported $0.92 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.92. HealthEquity had a return on equity of 12.04% and a net margin of 11.49%.The company had revenue of $325.80 million for the quarter, compared to the consensus estimate of $320.68 million. HealthEquity has set its FY 2026 guidance at 3.740-3.91 EPS. Analysts predict that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

Insider Transactions at HealthEquity

In other news, EVP Michael Henry Fiore sold 1,781 shares of the firm’s stock in a transaction dated Tuesday, October 7th. The shares were sold at an average price of $88.21, for a total value of $157,102.01. Following the transaction, the executive vice president directly owned 49,795 shares in the company, valued at approximately $4,392,416.95. This trade represents a 3.45% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Delano Ladd sold 6,000 shares of the firm’s stock in a transaction dated Friday, September 19th. The stock was sold at an average price of $94.11, for a total transaction of $564,660.00. Following the completion of the transaction, the executive vice president owned 79,456 shares in the company, valued at approximately $7,477,604.16. The trade was a 7.02% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.50% of the company’s stock.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.